Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJC9 pseudogene 1 (DNAJC9P1) is classified as a pseudogene, a genomic DNA sequence similar to a functional gene but typically non-functional itself. There is no evidence that DNAJC9P1 encodes a protein or has biological activity; it is annotated as a non-coding, presumably non-expressed locus, and not considered a therapeutic target or a gene with known biological function, disease links, or drug interactions[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAJC9 pseudogene 1 (DNAJC9P1).